Tag: MREO Stock


Mereo Biopharma Group Plc – ADR (NASDAQ: MREO) Gains after Announcing Positive Data from Study

Mereo BioPharma Group plc – ADR (NASDAQ: MREO), which has a market capitalization of $343.14 million, was founded in 2015. Mereo BioPharma Group is a UK-based clinical-stage biopharmaceutical company. It primarily focuses on treatments for oncology and some rare diseases. Last week, the company announced positive Desmosine Biomarker Data and […]